Search





Search





Markets
/
Stocks
/
dwtx
/

Dogwood Therapeutics Inc

DWTX

Add to Watchlist

1.640USD

+0.060+3.80%

Close 07-31 16:00（ET）Quotes delayed by 15 min

54.78MMarket Cap

LossP/E TTM

Dogwood Therapeutics Inc

1.640

+0.060+3.80%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

DWTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Dogwood Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

2.04%-4.59M

40.68%-3.64M

-259.59%-3.27M

-395.98%-4.03M

-399.52%-4.68M

-317.34%-6.13M

5.24%-910.14K

-9.34%-811.75K

44.81%-937.41K

45.00%-1.47M

61.32%-960.45K

79.70%-742.41K

36.05%-1.70M

48.41%-2.67M

6.25%-2.48M

-32.96%-3.66M

48.05%-2.66M

-126.48%-5.18M

-373.93%-2.65M

---2.75M

---5.11M

-384.69%-2.29M

-9.86%-558.89K

---471.71K

---508.71K

Net income from continuing operations

54.36%-4.99M

51.08%-3.78M

-590.35%-15.74M

-262.66%-3.81M

-746.02%-10.92M

-600.51%-7.73M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

---4.28M

---3.06M

-918.06%-6.50M

-235.55%-2.72M

---638.59K

---811.82K

Operating gains losses

-100.00%0.00

----

--17.26K

--17.02K

--12.18K

----

Deferred tax

-78.95%40.10K

6430.22%31.84K

---1.44K

--149.00

--190.54K

---503.00

----

Other non-cash items

-99.63%22.70K

-102.56%-93.47K

--12.06M

---5.17K

--6.19M

--3.65M

----

100.00%0.00

-100.00%0.00

--0.00

-357.90%-31.31K

19.69%14.75K

--12.14K

--12.32K

Change in working capital

53.59%-112.80K

102.05%44.30K

-71.66%361.73K

-432.09%-296.02K

-213.06%-243.02K

-320.30%-2.16M

910.37%1.28M

-83.40%89.14K

162.62%214.95K

33.76%-514.30K

275.94%126.32K

523.27%536.83K

-129.28%-343.28K

2.80%-776.38K

-105.40%-71.79K

-108.47%-126.83K

156.34%1.17M

32.50%-798.75K

783.91%1.33M

--1.50M

---2.08M

-864.75%-1.18M

-48.28%150.39K

--154.74K

--290.79K

-Change in prepaid expenses

302.30%288.89K

65.79%-377.56K

-161.15%-227.66K

41.57%324.72K

2001.49%71.81K

-186.17%-1.10M

133.84%372.28K

-59.48%229.37K

-97.73%3.42K

-43.29%-385.71K

-42.21%159.20K

484.14%566.08K

-73.60%150.69K

68.24%-269.18K

-72.69%275.48K

-108.38%-147.36K

128.38%570.81K

47.56%-847.59K

879.24%1.01M

--1.76M

---2.01M

-67391.88%-1.62M

-53.53%103.02K

--2.40K

--221.69K

Cash from non-recurring investing activities

Cash from operating activities

2.04%-4.59M

40.68%-3.64M

-259.59%-3.27M

-395.98%-4.03M

-399.52%-4.68M

-317.34%-6.13M

5.24%-910.14K

-9.34%-811.75K

44.81%-937.41K

45.00%-1.47M

61.32%-960.45K

79.70%-742.41K

36.05%-1.70M

48.41%-2.67M

6.25%-2.48M

-32.96%-3.66M

48.05%-2.66M

-126.48%-5.18M

-373.93%-2.65M

---2.75M

---5.11M

-384.69%-2.29M

-9.86%-558.89K

---471.71K

---508.71K

Investing cash flow

Net cash flow from business transactions

----

-100.00%0.00

----

--3.76M

----

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

----

-100.00%0.00

----

--3.76M

----

Financing cash flow

Cash flow from continuous financing activities

53.16%11.29M

-99.79%32.56K

100.00%0.00

-108.27%-120.13K

--7.37M

--15.32M

-106.07%-70.23K

--1.45M

----

100.00%0.00

-74.73%1.16M

----

--0.00

---86.00K

--4.58M

--0.00

100.00%0.00

-100.00%0.00

--0.00

---97.60K

5398.08%31.58M

187.58%9.48K

--574.43K

---10.82K

Net cash flow from debt Issuance/repayment

----

--15.32M

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--125.00K

--580.00K

--0.00

Net cash flow from common stock issuance/repurchase

160.67%11.40M

--86.37K

--0.00

---120.13K

--4.37M

----

--31.35M

----

Proceeds from issuance of warrants

--132.00

----

--0.00

--1.16M

----

--0.00

-100.00%0.00

--0.00

--197.56K

--176.25K

----

Net cash flow from other financing activities

-103.54%-106.27K

-100.35%-53.80K

100.00%0.00

-100.00%0.00

--3.00M

--15.32M

---70.23K

--1.45M

----

---86.00K

--4.58M

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---295.17K

1129.44%57.34K

-967.16%-115.52K

---5.57K

---10.82K

Net cash from non-recurrent financing activities

Net cash from financing activities

53.16%11.29M

-99.79%32.56K

100.00%0.00

-108.27%-120.13K

--7.37M

--15.32M

-106.07%-70.23K

--1.45M

----

100.00%0.00

-74.73%1.16M

----

--0.00

---86.00K

--4.58M

--0.00

100.00%0.00

-100.00%0.00

--0.00

---97.60K

5398.08%31.58M

187.58%9.48K

--574.43K

---10.82K

Net cash flow

Beginning cash balance

-56.06%6.52M

79.01%10.13M

343.77%13.40M

637.08%17.54M

347.64%14.85M

18.20%5.66M

-34.20%3.02M

-55.38%2.38M

-52.82%3.32M

-51.10%4.79M

-40.35%4.59M

-53.03%5.33M

-49.81%7.03M

-48.98%9.79M

-64.76%7.70M

-53.83%11.35M

-52.99%14.01M

3744.32%19.19M

1982.52%21.84M

--24.59M

--29.80M

141.49%499.08K

44.38%1.05M

--206.67K

--726.20K

Current period cash flow changes

149.09%6.70M

-139.19%-3.60M

-234.17%-3.28M

-745.62%-4.14M

387.07%2.69M

725.58%9.19M

-600.21%-980.36K

186.29%640.65K

44.81%-937.41K

46.72%-1.47M

-90.64%195.99K

79.70%-742.41K

36.05%-1.70M

46.75%-2.76M

179.03%2.09M

-32.96%-3.66M

49.02%-2.66M

-117.68%-5.18M

-382.11%-2.65M

---2.75M

---5.21M

28421.64%29.30M

-5.75%-549.41K

--102.72K

---519.53K

Effect of exchange rate changes

-184.73%-1.04K

101.84%2.66K

---3.31K

--10.06K

--1.23K

---144.59K

----

Ending cash balance

-24.58%13.23M

-56.06%6.52M

396.45%10.13M

343.77%13.40M

637.08%17.54M

347.64%14.85M

-57.38%2.04M

-34.20%3.02M

-55.38%2.38M

-52.82%3.32M

-51.10%4.79M

-40.35%4.59M

-53.03%5.33M

-49.81%7.03M

-48.98%9.79M

-64.76%7.70M

-53.83%11.35M

-52.99%14.01M

3744.32%19.19M

--21.84M

--24.59M

9530.55%29.80M

141.49%499.08K

--309.38K

--206.67K

Free cash flow

----

40.68%-3.64M

----

---6.13M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Dogwood Therapeutics Inc Generate?



Dogwood Therapeutics Inc generated -15.62M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Dogwood Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Dogwood Therapeutics Inc's operating cash flow increased by -77.67% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Dogwood Therapeutics Inc's Financing Cash Flow Changed?



Dogwood Therapeutics Inc used 7.28M in financing activities in the latest quarter.

What is free cash flow and why does it matter for DWTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Dogwood Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -15.62M reflecting a -77.67% change from the previous year.